DE10299034I2 - Formulierung zur topischen Anwendung am Auge, die Olopatadine enthalten, zur Behandlung von allergischen Augenerkrankungen. - Google Patents
Formulierung zur topischen Anwendung am Auge, die Olopatadine enthalten, zur Behandlung von allergischen Augenerkrankungen.Info
- Publication number
- DE10299034I2 DE10299034I2 DE2002199034 DE10299034C DE10299034I2 DE 10299034 I2 DE10299034 I2 DE 10299034I2 DE 2002199034 DE2002199034 DE 2002199034 DE 10299034 C DE10299034 C DE 10299034C DE 10299034 I2 DE10299034 I2 DE 10299034I2
- Authority
- DE
- Germany
- Prior art keywords
- eye
- formulation
- allergic
- treatment
- topical use
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/469,729 US5641805A (en) | 1995-06-06 | 1995-06-06 | Topical ophthalmic formulations for treating allergic eye diseases |
PCT/US1996/006289 WO1996039147A2 (en) | 1995-06-06 | 1996-05-03 | Topical ophthalmic formulations containing doxepin derivatives for treating allergic eye diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
DE10299034I1 DE10299034I1 (de) | 2003-01-23 |
DE10299034I2 true DE10299034I2 (de) | 2005-07-07 |
Family
ID=23864859
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69622527T Expired - Lifetime DE69622527T2 (de) | 1995-06-06 | 1996-05-03 | Formulierung zur topischen anwendung am auge, die olopatadine enthalten, zur behandlung von allergischen augenerkrankungen |
DE2002199034 Active DE10299034I2 (de) | 1995-06-06 | 1996-05-03 | Formulierung zur topischen Anwendung am Auge, die Olopatadine enthalten, zur Behandlung von allergischen Augenerkrankungen. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69622527T Expired - Lifetime DE69622527T2 (de) | 1995-06-06 | 1996-05-03 | Formulierung zur topischen anwendung am auge, die olopatadine enthalten, zur behandlung von allergischen augenerkrankungen |
Country Status (20)
Country | Link |
---|---|
US (1) | US5641805A (de) |
EP (1) | EP0799044B1 (de) |
JP (1) | JP3068858B2 (de) |
KR (1) | KR100202155B1 (de) |
CN (1) | CN1082367C (de) |
AT (1) | ATE220906T1 (de) |
AU (1) | AU698854B2 (de) |
CA (1) | CA2195094C (de) |
DE (2) | DE69622527T2 (de) |
DK (1) | DK0799044T3 (de) |
ES (1) | ES2179198T3 (de) |
FI (1) | FI970489A0 (de) |
LU (1) | LU90969I2 (de) |
MX (1) | MX9701013A (de) |
MY (1) | MY116651A (de) |
NL (1) | NL300101I2 (de) |
NO (1) | NO311637B1 (de) |
PT (1) | PT799044E (de) |
TW (1) | TW438588B (de) |
WO (1) | WO1996039147A2 (de) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5859000A (en) * | 1995-06-07 | 1999-01-12 | University Of Utah Research Foundation | Method for reducing mast cell mediated allergic reactions |
KR100598723B1 (ko) * | 1998-07-14 | 2006-07-11 | 알콘 매뉴팩츄어링, 리미티드 | 비알레르기성 안염증 질환 치료 및 안혈관신생 예방용약제를 제조하기 위한11-(3-디메틸아미노프로필리덴)-6,11-디하이드로디벤즈[β,ε]옥세핀-2-아세트산의 용도 |
US6174914B1 (en) | 1999-06-15 | 2001-01-16 | Alcon Laboratories, Inc. | Method of inhibiting cytokine release from human ocular cells |
CA2374002A1 (en) | 1999-06-18 | 2000-12-28 | Alcon Laboratories, Inc. | Topical ophthalmic mast cell stabilizers for treating allergic eye diseases |
ATE291913T1 (de) | 2000-01-25 | 2005-04-15 | Alcon Inc | Antiallergische ophthalmische zubereitungen, geeignet zur anwendung mit kontaktlinsen |
CN1173697C (zh) | 2000-05-19 | 2004-11-03 | 爱尔康公司 | 用于治疗过敏性疾病的苯胺二硫化物衍生物 |
CN1172666C (zh) | 2000-05-19 | 2004-10-27 | 爱尔康公司 | 用于治疗过敏性疾病的含有苯甲酰胺二硫化物衍生物的组合物 |
AU5567501A (en) | 2000-05-19 | 2001-12-03 | Alcon Universal Ltd | Disulfide derivatives useful for treating allergic diseases |
AU2002316887A1 (en) * | 2001-05-03 | 2002-11-18 | Novartis Ag | Anti-ige antibody to treat ocular allergies |
TWI231759B (en) * | 2001-06-27 | 2005-05-01 | Alcon Inc | Olopatadine formulations for topical administration |
US7977376B2 (en) | 2001-06-27 | 2011-07-12 | Novartis Ag | Olopatadine formulations for topical nasal administration |
BR0214643A (pt) * | 2001-12-05 | 2004-11-03 | Alcon Inc | Aplicação de um antagonista h1, e um esteróide seguro para tratar rinite |
US20050209312A1 (en) * | 2004-03-19 | 2005-09-22 | Bausch & Lomb Incorporated | Carboxylic acid derivatives of doxepin formulations preserved with low-irritation preservative |
US20050288283A1 (en) * | 2004-06-28 | 2005-12-29 | Alcon, Inc. | Topical formulations for treating allergic diseases |
CN103860540A (zh) * | 2004-11-24 | 2014-06-18 | 爱尔康公司 | 奥洛他定在治疗鼻子过敏或发炎状态的制剂制备中的用途 |
ES2437077T3 (es) * | 2005-07-08 | 2014-01-08 | Senju Pharmaceutical Co., Ltd. | Preparado oftálmico de absorción percutánea que comprende olopatadina |
DK3150209T3 (da) | 2006-03-31 | 2019-10-28 | Vistakon Pharmaceuticals Llc | Okulære allergibehandlinger |
US20080139531A1 (en) * | 2006-12-04 | 2008-06-12 | Alcon Manufacturing Ltd. | Use of connective tissue mast cell stabilizers to facilitate ocular surface re-epithelization and wound repair |
ES2781090T3 (es) | 2007-02-07 | 2020-08-28 | Novartis Ag | Formulaciones de olopatadina para administración nasal tópica |
US20090182035A1 (en) * | 2007-04-11 | 2009-07-16 | Alcon Research, Ltd. | Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis |
JP2010523695A (ja) * | 2007-04-11 | 2010-07-15 | アルコン リサーチ, リミテッド | アレルギー性鼻炎およびアレルギー性結膜炎を処置するためのTNFαのインヒビターおよび抗ヒスタミン薬の使用 |
US20100227917A1 (en) * | 2007-09-06 | 2010-09-09 | Masashi Nakakura | EYE DROP CONTAINING DIBENZ[b,e]OXEPIN DERIVATIVE |
US10517839B2 (en) * | 2008-06-09 | 2019-12-31 | Cornell University | Mast cell inhibition in diseases of the retina and vitreous |
IT1397503B1 (it) | 2009-04-21 | 2013-01-16 | F S I Fabbrica Italiana Sint | Processo per la preparazione di olopatadina |
MX2012000539A (es) * | 2009-07-17 | 2012-02-28 | Alcon Res Ltd | Regimen de rocio nasal de olopatadina para niños. |
WO2011027322A1 (en) | 2009-09-03 | 2011-03-10 | Ranbaxy Laboratories Limited | Extended release dosage form containing olopatadine for oral administration |
MX2012003693A (es) * | 2009-10-01 | 2012-04-19 | Alcon Res Ltd | Composiciones de olopatadine y usos de las mismas. |
TW201206936A (en) | 2010-07-19 | 2012-02-16 | Alcon Res Ltd | Methods and compositions for the treatment of allergy |
TWI544922B (zh) | 2011-05-19 | 2016-08-11 | 愛爾康研究有限公司 | 高濃度歐羅派特錠(olopatadine)眼用組成物 |
CN103202833A (zh) * | 2012-12-25 | 2013-07-17 | 常州市亚邦医药研究所有限公司 | 一种奥洛他定或其盐的药用组合物及其制备方法 |
US20150119455A1 (en) * | 2013-10-31 | 2015-04-30 | Nephron Pharmaceuticals Corporation | Formulation |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4370324A (en) * | 1980-09-17 | 1983-01-25 | Bernstein Joel E | Method and composition for treating and preventing irritation of the eyes |
US4923892A (en) * | 1985-08-17 | 1990-05-08 | Burroughs Wellcome Co. | Tricyclic aromatic compounds |
GB8520662D0 (en) * | 1985-08-17 | 1985-09-25 | Wellcome Found | Tricyclic aromatic compounds |
JPS6310784A (ja) * | 1986-03-03 | 1988-01-18 | Kyowa Hakko Kogyo Co Ltd | 抗アレルギー剤 |
-
1995
- 1995-06-06 US US08/469,729 patent/US5641805A/en not_active Expired - Lifetime
-
1996
- 1996-05-03 CA CA002195094A patent/CA2195094C/en not_active Expired - Lifetime
- 1996-05-03 WO PCT/US1996/006289 patent/WO1996039147A2/en active IP Right Grant
- 1996-05-03 DE DE69622527T patent/DE69622527T2/de not_active Expired - Lifetime
- 1996-05-03 AT AT96915500T patent/ATE220906T1/de active
- 1996-05-03 CN CN96190605A patent/CN1082367C/zh not_active Ceased
- 1996-05-03 KR KR1019970700721A patent/KR100202155B1/ko active IP Right Review Request
- 1996-05-03 DE DE2002199034 patent/DE10299034I2/de active Active
- 1996-05-03 EP EP96915500A patent/EP0799044B1/de not_active Expired - Lifetime
- 1996-05-03 DK DK96915500T patent/DK0799044T3/da active
- 1996-05-03 JP JP9500510A patent/JP3068858B2/ja not_active Expired - Lifetime
- 1996-05-03 PT PT96915500T patent/PT799044E/pt unknown
- 1996-05-03 AU AU57261/96A patent/AU698854B2/en not_active Expired
- 1996-05-03 ES ES96915500T patent/ES2179198T3/es not_active Expired - Lifetime
- 1996-05-03 MX MX9701013A patent/MX9701013A/es unknown
- 1996-05-14 MY MYPI96001818A patent/MY116651A/en unknown
- 1996-06-04 TW TW085106668A patent/TW438588B/zh not_active IP Right Cessation
-
1997
- 1997-02-05 FI FI970489A patent/FI970489A0/fi unknown
- 1997-02-05 NO NO19970517A patent/NO311637B1/no not_active IP Right Cessation
-
2002
- 2002-09-19 NL NL300101C patent/NL300101I2/nl unknown
- 2002-10-02 LU LU90969C patent/LU90969I2/fr unknown
Also Published As
Publication number | Publication date |
---|---|
MX9701013A (es) | 1997-05-31 |
KR100202155B1 (ko) | 1999-06-15 |
DE69622527D1 (de) | 2002-08-29 |
KR970704452A (ko) | 1997-09-06 |
CA2195094A1 (en) | 1996-12-12 |
JP3068858B2 (ja) | 2000-07-24 |
DE69622527T2 (de) | 2002-12-05 |
MY116651A (en) | 2004-03-31 |
DE10299034I1 (de) | 2003-01-23 |
WO1996039147A3 (en) | 1997-02-20 |
DK0799044T3 (da) | 2002-10-14 |
FI970489A (fi) | 1997-02-05 |
NO970517L (no) | 1997-04-03 |
AU698854B2 (en) | 1998-11-12 |
US5641805A (en) | 1997-06-24 |
WO1996039147A2 (en) | 1996-12-12 |
JPH09510235A (ja) | 1997-10-14 |
NL300101I1 (nl) | 2002-12-02 |
NL300101I2 (nl) | 2003-01-06 |
AU5726196A (en) | 1996-12-24 |
CA2195094C (en) | 2002-02-26 |
LU90969I2 (fr) | 2002-12-02 |
TW438588B (en) | 2001-06-07 |
NO970517D0 (no) | 1997-02-05 |
FI970489A0 (fi) | 1997-02-05 |
NO311637B1 (no) | 2001-12-27 |
ES2179198T3 (es) | 2003-01-16 |
CN1161000A (zh) | 1997-10-01 |
PT799044E (pt) | 2002-11-29 |
EP0799044A2 (de) | 1997-10-08 |
EP0799044B1 (de) | 2002-07-24 |
ATE220906T1 (de) | 2002-08-15 |
CN1082367C (zh) | 2002-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE10299034I2 (de) | Formulierung zur topischen Anwendung am Auge, die Olopatadine enthalten, zur Behandlung von allergischen Augenerkrankungen. | |
MA26901A1 (fr) | Nouvelle composition pharmaceutique | |
ES2172670T3 (es) | Pirrolpirimidinas y procedimientos para su preparacion. | |
ATE179888T1 (de) | Ophthalmische zubereitung zur behandlung oder prävention von trockenem auge und krankheiten, die dadurch verursacht werden, enthaltend 12- sulfodehydroabietsäure | |
CA2321560A1 (en) | The use of a protein tyrosine inhibitor such as genistein in the treatment of diabetic retinopathy or ocular inflammation | |
GR1000611B (el) | Μεθοδος για την παρασκευη οφθαλμικων συνθεσεων κυκλοσπορινης. | |
DE69930271D1 (de) | Medizinische zusammensetzungen zur behandlung von augenerkrankungen | |
DE69501359D1 (de) | Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina | |
ATE326965T1 (de) | Pharmazeutische zusammensetzung zur behandlung von autoimmunkrankheiten | |
EP0842663A4 (de) | Ophtalmika | |
DE69013431T2 (de) | Anthocyanidine zur Behandlung von Augenkrankheiten. | |
AP9901474A0 (en) | Pharmaceutical composition for treating viral diseases. | |
IE870577L (en) | Topical amide preparation | |
BR9713044A (pt) | Composto, uso de um composto, processo para sua preparação,e, formulação farmacêutica. | |
DE69620573D1 (de) | Mittel zur verminderung des augeninnendrucks | |
RU95107870A (ru) | Способ лечения послеоперационной цилиохориоидальной отслойки |